Published in Chest on June 01, 1998
Molecular and physiological characterization of RV remodeling in a murine model of pulmonary stenosis. Am J Physiol Heart Circ Physiol (2008) 1.14
The adult patient with eisenmenger syndrome: a medical update after dana point part I: epidemiology, clinical aspects and diagnostic options. Curr Cardiol Rev (2010) 1.06
Incidence of secondary pulmonary hypertension in adults with atrial septal or sinus venosus defects. Heart (1999) 0.92
Estimated right ventricular systolic pressure during exercise stress echocardiography in patients with suspected coronary artery disease. Can J Cardiol (2010) 0.81
Pulmonary arterial hypertension: dipping into the reserve. Chest (1998) 0.75
Impact of age on pulmonary artery systolic pressures at rest and with exercise. Echo Res Pract (2016) 0.75
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med (1996) 8.02
Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med (1993) 4.91
How valid are utilization review tools in assessing appropriate use of acute care beds? CMAJ (2000) 4.64
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Ann Intern Med (2000) 4.07
FLT3: ITDoes matter in leukemia. Leukemia (2003) 3.92
Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation (2001) 3.89
Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Intern Med (1991) 2.88
Home monitoring service improves mean arterial pressure in patients with essential hypertension. A randomized, controlled trial. Ann Intern Med (2001) 2.31
A comparison of albuterol administered by metered dose inhaler (and holding chamber) or wet nebulizer in acute asthma. Chest (1993) 2.15
Hormonal manipulation of benign metastasizing leiomyomas: report of two cases and review of the literature. J Clin Endocrinol Metab (2004) 2.11
Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. N Engl J Med (1987) 2.05
Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group. Circulation (1997) 2.03
Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role. Chest (1995) 1.92
Long-term postthoracotomy pain. Chest (1991) 1.85
A FLT3 tyrosine kinase inhibitor is selectively cytotoxic to acute myeloid leukemia blasts harboring FLT3 internal tandem duplication mutations. Blood (2001) 1.73
The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth. Neuron (1992) 1.72
Expression of the hematopoietic growth factor receptor FLT3 (STK-1/Flk2) in human leukemias. Blood (1996) 1.70
Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room. Am J Med (1987) 1.65
Members of the Jagged/Notch gene families are expressed in injured arteries and regulate cell phenotype via alterations in cell matrix and cell-cell interaction. Am J Pathol (2001) 1.61
The increasing incidence of lung adenocarcinoma: reality or artefact? A review of the epidemiology of lung adenocarcinoma. Int J Epidemiol (1997) 1.59
The association of transcribed genes with the nuclear matrix of Drosophila cells during heat shock. Nucleic Acids Res (1985) 1.57
Congenital diaphragmatic hernia: arterial structural changes and persistent pulmonary hypertension after surgical repair. J Pediatr (1985) 1.52
Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma. Bone Marrow Transplant (1998) 1.51
Constitutive activation of FLT3 stimulates multiple intracellular signal transducers and results in transformation. Leukemia (2000) 1.50
The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer. Curr Oncol (2010) 1.43
Uses and misuses of oxygen in hospitalized patients. Am J Med (1992) 1.41
Mitral stenosis obscuring the diagnosis of plexogenic pulmonary arteriopathy and familial pulmonary hypertension. Thorax (2000) 1.39
Occurrence of phosphorylated residues in predicted beta-turns: implications for beta-turn participation in control mechanisms. Biochem Biophys Res Commun (1977) 1.38
Human AML cells in NOD/SCID mice: engraftment potential and gene expression. Leukemia (2002) 1.30
Mutation of the cyclin-dependent kinase phosphorylation site in simian virus 40 (SV40) large T antigen specifically blocks SV40 origin DNA unwinding. J Virol (1993) 1.30
The relationship between pulmonary function and dyspnea in obstructive lung disease. Chest (1989) 1.30
Initiation of SV40 DNA replication: mechanism and control. Cold Spring Harb Symp Quant Biol (1991) 1.21
Inhibition of FLT3-mediated transformation by use of a tyrosine kinase inhibitor. Leukemia (2001) 1.20
Pulmonary toxicity of antineoplastic therapy. Semin Oncol (1992) 1.18
Mutations of FLT3/ITD confer resistance to multiple tyrosine kinase inhibitors. Leukemia (2012) 1.18
The association of transcriptionally active genes with the nuclear matrix of the chicken oviduct. Nucleic Acids Res (1983) 1.17
Combinations of the FLT3 inhibitor CEP-701 and chemotherapy synergistically kill infant and childhood MLL-rearranged ALL cells in a sequence-dependent manner. Leukemia (2006) 1.15
Recombinant 52 kDa Ro(SSA) ELISA detects autoantibodies in Sjögren's syndrome sera that go undetected by conventional serologic assays. J Rheumatol (1997) 1.12
Inhibition of the transforming activity of FLT3 internal tandem duplication mutants from AML patients by a tyrosine kinase inhibitor. Leukemia (2002) 1.09
The 6-min walk test (6MW) as an efficacy endpoint in pulmonary arterial hypertension clinical trials: demonstration of a ceiling effect. Vascul Pharmacol (2005) 1.09
Short-term pulmonary vasodilation with L-arginine in pulmonary hypertension. Circulation (1995) 1.08
Congenital hydrocephalus in genetically engineered mice. Vet Pathol (2011) 1.06
Coordination of eating, drinking and breathing in adults. Chest (1989) 1.05
Further activation of FLT3 mutants by FLT3 ligand. Oncogene (2011) 1.04
Breast cancer and thoracic metastases: review of 119 patients. Thorax (1983) 1.04
Nonrandom distribution of repeated DNA sequences with respect to supercoiled loops and the nuclear matrix. Proc Natl Acad Sci U S A (1982) 1.04
Tnk1: a novel intracellular tyrosine kinase gene isolated from human umbilical cord blood CD34+/Lin-/CD38- stem/progenitor cells. Oncogene (1996) 1.03
Small cell lung cancer presenting as a solitary pulmonary nodule. Chest (1992) 1.00
Wegener's granulomatosis and relapsing polychondritis: a case report. J Rheumatol (1981) 0.98
Hemodynamic differences between continual positive and two types of negative pressure ventilation. Am Rev Respir Dis (1992) 0.97
Characterization of N-myc amplification units in human neuroblastoma cells. Mol Cell Biol (1988) 0.96
A non-transmembrane form of Jagged-1 regulates the formation of matrix-dependent chord-like structures. Biochem Biophys Res Commun (2000) 0.94
Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in acute lung injury. Circulation (2000) 0.94
Flexible modeling improves assessment of prognostic value of C-reactive protein in advanced non-small cell lung cancer. Br J Cancer (2010) 0.93
Treatment of small-cell lung cancer on protocol: potential bias of results. J Clin Oncol (1986) 0.93
Flt3high and Flt3low CD34+ progenitor cells isolated from human bone marrow are functionally distinct. Blood (1998) 0.92
Intranasal aerosolized insulin. Mixed-meal studies and long-term use in type I diabetes. N Engl J Med (1985) 0.92
Effect of chronic infusion of epoprostenol on echocardiographic right ventricular myocardial performance index and its relation to clinical outcome in patients with primary pulmonary hypertension. Am J Cardiol (2001) 0.92
FLT3 inhibitors: a paradigm for the development of targeted therapeutics for paediatric cancer. Eur J Cancer (2004) 0.91
Synergism between ipratropium and theophylline in asthma. Thorax (1981) 0.91
Erythropoietin: isolation by affinity chromatography with lectin-agarose derivatives. Proc Natl Acad Sci U S A (1977) 0.90
Vitreous concentration of topically applied brimonidine tartrate 0.2%. Ophthalmology (2001) 0.90
Screening for depressive symptoms in patients with unresectable lung cancer. Support Care Cancer (2007) 0.89
Pulmonary capillary endothelial metabolic function in chronic thromboembolic pulmonary hypertension. J Thromb Haemost (2008) 0.89
International differences in epidemiology of lung adenocarcinoma. Lung Cancer (1997) 0.88
Occult foreign-body aspiration in adults. JAMA (1982) 0.88
Small cell lung cancer presenting as a solitary pulmonary nodule. Cancer (1990) 0.88
Perfusion lung scanning: differentiation of primary from thromboembolic pulmonary hypertension. AJR Am J Roentgenol (1985) 0.87
The impact of Filgrastim schedule variation on hematopoietic recovery post-chemotherapy. Ann Oncol (1997) 0.85
Effect of caffeine on histamine bronchoprovocation in asthma. Thorax (1990) 0.85
Comparison of flow cytometry and laser scanning cytometry for the intracellular evaluation of adenoviral infectivity and p53 protein expression in gene therapy. Cytometry (1998) 0.85
Oral herpes simplex infection in bullous pemphigoid. Oral Surg Oral Med Oral Pathol (1986) 0.85
Effect of methylprednisolone on monocrotaline-induced pulmonary vascular disease and right ventricular hypertrophy. Lab Invest (1985) 0.85
Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in humans. Circulation (1999) 0.85
JAK3: expression and mapping to chromosome 19p12-13.1. Exp Hematol (1997) 0.85
Efficacy of Uniphyl, salbutamol, and their combination in asthmatic patients on high-dose inhaled steroids. Am J Respir Crit Care Med (1995) 0.84
The solitary pulmonary nodule. Decision analysis. Med Decis Making (1985) 0.84
Transgenic mice expressing Tel-FLT3, a constitutively activated form of FLT3, develop myeloproliferative disease. Leukemia (2007) 0.84
Pulmonary capillary endothelial dysfunction in early systemic sclerosis. Arthritis Rheum (2001) 0.84
Seasonal variation in plasma lipids, lipoproteins, apolipoprotein A-I and vitellogenin in the freshwater turtle, Chrysemys picta. Comp Biochem Physiol A Mol Integr Physiol (2001) 0.84
Effect of transcendental meditation on breathing and respiratory control. J Appl Physiol Respir Environ Exerc Physiol (1984) 0.83